Efficacy News and Research

RSS
Vanda presents additional data from tasimelteon Phase III studies at ENDO 2013

Vanda presents additional data from tasimelteon Phase III studies at ENDO 2013

Santarus, Pharming Group announce FDA acceptance of RUCONEST BLA

Santarus, Pharming Group announce FDA acceptance of RUCONEST BLA

Vaccine given to newborns 60% effective against rotavirus in Ghana

Vaccine given to newborns 60% effective against rotavirus in Ghana

Bazedoxifene used for treating osteoporosis stops growth of breast cancer cells

Bazedoxifene used for treating osteoporosis stops growth of breast cancer cells

Transition, Lilly amend agreement to address future development of TT-401

Transition, Lilly amend agreement to address future development of TT-401

Genmab, ADC Therapeutics agree to develop new antibody-drug conjugate product

Genmab, ADC Therapeutics agree to develop new antibody-drug conjugate product

Ibrutinib monotherapy shows efficacy in patients with MCL or DLBCL

Ibrutinib monotherapy shows efficacy in patients with MCL or DLBCL

Teva to present abstracts on AZILECT at MDS meeting

Teva to present abstracts on AZILECT at MDS meeting

Research: Deep brain stimulation is associated with weight loss trend in morbidly obese patients

Research: Deep brain stimulation is associated with weight loss trend in morbidly obese patients

Study demonstrates efficacy of canakinumab at tapering corticosteroid use in patients with SJIA

Study demonstrates efficacy of canakinumab at tapering corticosteroid use in patients with SJIA

Study provides new insight into how pyrazinamide works

Study provides new insight into how pyrazinamide works

Penn Medicine researchers identify key molecular player in recurrent breast cancer

Penn Medicine researchers identify key molecular player in recurrent breast cancer

PRISM Pharma announces closing of $15 million Series C financing

PRISM Pharma announces closing of $15 million Series C financing

Study: Tocilizumab is effective in children with juvenile idiopathic arthritis

Study: Tocilizumab is effective in children with juvenile idiopathic arthritis

AMPLE trial demonstrates similar safety profiles and efficacy between abatacept and adalimumab in RA

AMPLE trial demonstrates similar safety profiles and efficacy between abatacept and adalimumab in RA

Ustekinumab doses improve signs and symptoms of PsA with favourable safety profiles

Ustekinumab doses improve signs and symptoms of PsA with favourable safety profiles

Combination of Pressure Right and antiemetic drug therapy can reduce PONV with no adverse effects

Combination of Pressure Right and antiemetic drug therapy can reduce PONV with no adverse effects

Apremilast continues to demonstrate meaningful clinical responses in patients with psoriatic arthritis

Apremilast continues to demonstrate meaningful clinical responses in patients with psoriatic arthritis

Study demonstrates efficacy of ARASHI method at evaluating radiographic joint damage in RA

Study demonstrates efficacy of ARASHI method at evaluating radiographic joint damage in RA

Questions emerge as dust settles surrounding Plan B policy change

Questions emerge as dust settles surrounding Plan B policy change

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.